Ignite Creation Date:
2025-12-24 @ 11:42 PM
Ignite Modification Date:
2025-12-25 @ 9:34 PM
Study NCT ID:
NCT02890251
Status:
COMPLETED
Last Update Posted:
2023-02-15
First Post:
2016-08-18
Is NOT Gene Therapy:
False
Has Adverse Events:
False
Brief Title:
Visual Maturation in Premature Newborns According to Factors Influencing Its Development
Sponsor:
Central Hospital, Nancy, France
Organization:
Study Overview
Official Title:
Visual Maturation in Premature Newborns According to Factors Influencing Its Development
Status:
COMPLETED
Status Verified Date:
2023-02
Last Known Status:
None
Delayed Posting:
No
If Stopped, Why?:
Not Stopped
Has Expanded Access:
False
If Expanded Access, NCT#:
N/A
Has Expanded Access, NCT# Status:
N/A
Acronym:
PREMAVISION
Brief Summary:
The purpose is to describe the level of visual maturation of premature newborns at term equivalent age.
The secondary purpose is to determine factors associated to an altered level of visual maturation, through an exploratory approach.
The secondary purpose is to determine factors associated to an altered level of visual maturation, through an exploratory approach.
Detailed Description:
None
Study Oversight
Has Oversight DMC:
False
Is a FDA Regulated Drug?:
None
Is a FDA Regulated Device?:
None
Is an Unapproved Device?:
None
Is a PPSD?:
None
Is a US Export?:
None
Is an FDA AA801 Violation?: